12
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Treatment of recalcitrant verrucae vulgares with Nd:YAG laser hyperthermia (Regensburg's technique)-preliminary results in 31 cases

, , , &
Pages 39-42 | Received 10 Jun 1994, Accepted 16 Aug 1994, Published online: 12 Jul 2009
 

Abstract

The general principle in the treatment of cutaneous diseases with heat is based on the fact that diseased tissue is more sensitive to the effects of elevated temperature than normal tissue and thus is less able to recover after heat exposure. Different kinds of energy sources have been used to produce local hyperthermia, for example radiofrequency or microwave electromagnetic energy and ultrasonic energy). We report 31 patients with recalcitrant verrucae vulgares who were treated with Nd:YAG laser hyperthermia. Laser energy was applied up to three times with an interval of 3 weeks. The laser output was 10 W, spot size 8 mm and irradiation time up to 20 s which was repeated. With these settings it was possible to reach a surface temperature of about 40°C for 30 s. After hyperthermia, no side-effects such as coagulation, blisters or crusts were observed. An excellent response was achieved in 77% of the patients, but in 23% the method failed. No recurrence was seen during a follow-up period of up to 9 months. This method could be used in the treatment of finger, periungual and hand warts as well as warts on other parts of the body including the plantar surfaces.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.